US Bancorp’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.27M | Buy |
6,182
+155
| +3% | +$71.5K | ﹤0.01% | 746 |
|
|
2026
Q1 | $2.89M | Sell |
6,027
-18
| -0.3% | -$9.22K | ﹤0.01% | 757 |
|
|
2025
Q4 | $3.4M | Sell |
6,045
-474
| -7% | -$269K | ﹤0.01% | 714 |
|
|
2025
Q3 | $3.35M | Sell |
6,519
-16
| -0.2% | -$6.99K | ﹤0.01% | 711 |
|
|
2025
Q2 | $2.05M | Sell |
6,535
-853
| -12% | -$256K | ﹤0.01% | 850 |
|
|
2025
Q1 | $2.25M | Sell |
7,388
-847
| -10% | -$285K | ﹤0.01% | 805 |
|
|
2024
Q4 | $2.74M | Buy |
8,235
+135
| +2% | +$45.8K | ﹤0.01% | 766 |
|
|
2024
Q3 | $2.7M | Buy |
8,100
+3,016
| +59% | +$1.15M | ﹤0.01% | 760 |
|
|
2024
Q2 | $2.09M | Buy |
5,084
+268
| +6% | +$106K | ﹤0.01% | 831 |
|
|
2024
Q1 | $1.95M | Sell |
4,816
-453
| -9% | -$159K | ﹤0.01% | 856 |
|
|
2023
Q4 | $1.62M | Buy |
5,269
+98
| +2% | +$26.5K | ﹤0.01% | 906 |
|
|
2023
Q3 | $1.25M | Sell |
5,171
-354
| -6% | -$90.5K | ﹤0.01% | 967 |
|
|
2023
Q2 | $1.33M | Buy |
5,525
+257
| +5% | +$53.4K | ﹤0.01% | 951 |
|
|
2023
Q1 | $991K | Sell |
5,268
-458
| -8% | -$94.7K | ﹤0.01% | 1085 |
|
|
2022
Q4 | $1.22M | Buy |
5,726
+130
| +2% | +$26K | ﹤0.01% | 977 |
|
|
2022
Q3 | $880K | Buy |
5,596
+98
| +2% | +$15.6K | ﹤0.01% | 1116 |
|
|
2022
Q2 | $823K | Buy |
5,498
+1,198
| +28% | +$173K | ﹤0.01% | 1180 |
|
|
2022
Q1 | $703K | Sell |
4,300
-251
| -6% | -$41.4K | ﹤0.01% | 1350 |
|
|
2021
Q4 | $991K | Sell |
4,551
-1,098
| -19% | -$230K | ﹤0.01% | 1202 |
|
|
2021
Q3 | $1.07M | Sell |
5,649
-102
| -2% | -$18.6K | ﹤0.01% | 1155 |
|
|
2021
Q2 | $1.02M | Buy |
5,751
+84
| +1% | +$14.5K | ﹤0.01% | 1193 |
|
|
2021
Q1 | $930K | Buy |
5,667
+2,577
| +83% | +$394K | ﹤0.01% | 1172 |
|
|
2020
Q4 | $429K | Buy |
3,090
+60
| +2% | +$7.56K | ﹤0.01% | 1522 |
|
|
2020
Q3 | $338K | Sell |
3,030
-511
| -14% | -$59.1K | ﹤0.01% | 1551 |
|
|
2020
Q2 | $330K | Buy |
3,541
+423
| +14% | +$36K | ﹤0.01% | 1518 |
|
|
2020
Q1 | $228K | Buy |
3,118
+1,395
| +81% | +$121K | ﹤0.01% | 1595 |
|
|
2019
Q4 | $146K | Buy |
1,723
+85
| +5% | +$6.58K | ﹤0.01% | 1987 |
|
|
2019
Q3 | $137K | Sell |
1,638
-594
| -27% | -$44.9K | ﹤0.01% | 1998 |
|
|
2019
Q2 | $145K | Buy |
2,232
+116
| +5% | +$6.68K | ﹤0.01% | 2010 |
|
|
2019
Q1 | $124K | Sell |
2,116
-444
| -17% | -$26.5K | ﹤0.01% | 2079 |
|
|
2018
Q4 | $136K | Sell |
2,560
-6,651
| -72% | -$365K | ﹤0.01% | 1958 |
|
|
2018
Q3 | $552K | Buy |
9,211
+1,987
| +28% | +$109K | ﹤0.01% | 1403 |
|
|
2018
Q2 | $310K | Buy |
+7,224
| New | +$292K | ﹤0.01% | 1650 |
|
|
2018
Q1 | – | Sell |
-165
| Closed | -$6K | – | 3657 |
|
|
2017
Q4 | $6K | Hold |
165
| – | – | ﹤0.01% | 3282 |
|
|
2017
Q3 | $5K | Hold |
165
| – | – | ﹤0.01% | 3258 |
|
|
2017
Q2 | $5K | Sell |
165
-135
| -45% | -$3.79K | ﹤0.01% | 3220 |
|
|
2017
Q1 | $9K | Buy |
+300
| New | +$9.68K | ﹤0.01% | 3067 |
|
Other funds holding MEDP
WA
US Bancorp's MEDP Position: Q2 2026 in Review
US Bancorp increased its Medpace (MEDP) stake by 2.6% in Q2 2026, buying an estimated $71.5K and bringing the position to 6,182 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #746.
US Bancorp first reported a position in MEDP in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.4M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- US Bancorp held 6,182 shares of Medpace worth $3.27M as of Q2 2026.
- US Bancorp bought 155 Medpace shares in Q2 2026, an estimated $71.5K.
- Medpace made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #746 holding.
- US Bancorp first reported a position in Medpace in Q1 2017 and has held it in 37 quarters since.
- US Bancorp's Medpace position peaked at $3.4M in Q4 2025.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.